Collaboration to Advance and Establish Standards for Focused Ultrasound Treatment
By MedImaging International staff writers Posted on 16 Sep 2013 |
A new initiative has been established to create a state-of-the-art resource center for clinicians and scientists working on high-intensity, focused ultrasound therapy, developing clinical evidence in oncology and establishing best practices, treatment standards and protocols.
The Focused Ultrasound Foundation (Charlottesville, VA, USA) and Philips Healthcare (Best, The Netherlands) have entered into a partnership with The Institute of Cancer Research (ICR; London, UK) and The Royal Marsden NHS (National Health Service) Foundation Trust. The collaboration will create a focal point for ultrasound therapy research center at the ICR and The Royal Marsden (London, UK) under the international Focused Ultrasound Foundation Centers of Excellence Program.
Focused ultrasound concentrates ultrasound energy with high precision on target tissue in the body to thermally destroy tissue. The technology is combined with image guidance to identify, target, and monitor the treatment in real time. The initiative will launch the fall of 2013 with a clinical trial to assess treatment of bone metastases in cancer patients. A similar center was established at the University of Virginia (Charlottesville, USA) in 2009 to advance the use of focused ultrasound, with an emphasis on brain disorders.
“High-intensity, focused ultrasound therapy has tremendous potential in oncology and many other key clinical areas,” noted Gail ter Haar, DSc, coordinator of the initiative. “To achieve this, we need to collaborate in new ways, establish standards for consistent delivery of treatment and train those who will deliver that care. All of that will be happening here, thanks to the Focused Ultrasound Foundation. We are excited and honored to be a part of the network whose aim is to improve treatment outcomes for patients around the world.”
The Focused Ultrasound Foundation is the catalyst for the collaboration and its leadership will actively work with the ICR, The Royal Marsden, and Philips to help guide new developments towards standard-setting translational and clinical research, training, and treatment. In establishing the Focused Ultrasound Centers of Excellence Program, the Foundation brings together the best people and resources at key research sites worldwide in the dynamic multidisciplinary setting necessary to foster those activities critical to accelerating progress towards optimal patient outcomes.
“The new initiative established at the ICR and The Royal Marsden under the Focused Ultrasound Foundation Centers of Excellence Program is an important step forward for the technology,” noted Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation. “Our Centers of Excellence not only demonstrate exceptional technical and clinical expertise in the field of focused ultrasound, but also contribute to a synergistic network, leveraging expertise and sharing best practices.”
“Our contribution to the center will help to bring focused ultrasound technology to a higher level of maturity and shape the standard of care for patients around the world,” said Falko Busse, general manager MR Therapy at Philips Healthcare. “The ICR and The Royal Marsden are a perfect choice, being established global leaders in cancer research with an impressive track record of bringing new technologies and approaches to cancer care along with rigorous evidence-based standards. Prof. ter Haar and her group are pioneers in focused ultrasound therapy and are particularly strong in the standardization necessary for widespread adoption.”
The center will be led by Prof. Gail ter Haar and Prof. Nandita deSouza. Prof. ter Haar heads the ICR’s therapy ultrasound team. She is a leading physicist in the field, having researched the basic science behind the technique, participating in early clinical trials and advancing device development. Prof. deSouza is the new initiative’s clinical director. She is the lead academic radiologist at the ICR and The Royal Marsden, with an international reputation in MRI, and has run pilot clinical trials of MR-guided thermal therapies.
Related Links:
Focused Ultrasound Foundation
Philips Healthcare
Institute of Cancer Research
The Focused Ultrasound Foundation (Charlottesville, VA, USA) and Philips Healthcare (Best, The Netherlands) have entered into a partnership with The Institute of Cancer Research (ICR; London, UK) and The Royal Marsden NHS (National Health Service) Foundation Trust. The collaboration will create a focal point for ultrasound therapy research center at the ICR and The Royal Marsden (London, UK) under the international Focused Ultrasound Foundation Centers of Excellence Program.
Focused ultrasound concentrates ultrasound energy with high precision on target tissue in the body to thermally destroy tissue. The technology is combined with image guidance to identify, target, and monitor the treatment in real time. The initiative will launch the fall of 2013 with a clinical trial to assess treatment of bone metastases in cancer patients. A similar center was established at the University of Virginia (Charlottesville, USA) in 2009 to advance the use of focused ultrasound, with an emphasis on brain disorders.
“High-intensity, focused ultrasound therapy has tremendous potential in oncology and many other key clinical areas,” noted Gail ter Haar, DSc, coordinator of the initiative. “To achieve this, we need to collaborate in new ways, establish standards for consistent delivery of treatment and train those who will deliver that care. All of that will be happening here, thanks to the Focused Ultrasound Foundation. We are excited and honored to be a part of the network whose aim is to improve treatment outcomes for patients around the world.”
The Focused Ultrasound Foundation is the catalyst for the collaboration and its leadership will actively work with the ICR, The Royal Marsden, and Philips to help guide new developments towards standard-setting translational and clinical research, training, and treatment. In establishing the Focused Ultrasound Centers of Excellence Program, the Foundation brings together the best people and resources at key research sites worldwide in the dynamic multidisciplinary setting necessary to foster those activities critical to accelerating progress towards optimal patient outcomes.
“The new initiative established at the ICR and The Royal Marsden under the Focused Ultrasound Foundation Centers of Excellence Program is an important step forward for the technology,” noted Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation. “Our Centers of Excellence not only demonstrate exceptional technical and clinical expertise in the field of focused ultrasound, but also contribute to a synergistic network, leveraging expertise and sharing best practices.”
“Our contribution to the center will help to bring focused ultrasound technology to a higher level of maturity and shape the standard of care for patients around the world,” said Falko Busse, general manager MR Therapy at Philips Healthcare. “The ICR and The Royal Marsden are a perfect choice, being established global leaders in cancer research with an impressive track record of bringing new technologies and approaches to cancer care along with rigorous evidence-based standards. Prof. ter Haar and her group are pioneers in focused ultrasound therapy and are particularly strong in the standardization necessary for widespread adoption.”
The center will be led by Prof. Gail ter Haar and Prof. Nandita deSouza. Prof. ter Haar heads the ICR’s therapy ultrasound team. She is a leading physicist in the field, having researched the basic science behind the technique, participating in early clinical trials and advancing device development. Prof. deSouza is the new initiative’s clinical director. She is the lead academic radiologist at the ICR and The Royal Marsden, with an international reputation in MRI, and has run pilot clinical trials of MR-guided thermal therapies.
Related Links:
Focused Ultrasound Foundation
Philips Healthcare
Institute of Cancer Research
Latest Industry News News
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more